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INTRODUCTION 
 
Life expectancy in Europe has generally increased in 
recent decades. In 2012, 17% of the European Union 
population was aged 65 years or older, a percentage 
expected to rise to 25% by 2035, and to 30% in 2060 
[1].  However, a longer life expectancy does not 
necessarily mean healthy ageing; it can mean extra 
years of suffering chronic disease, particularly 
metabolic illnesses such us obesity and diabetes 
mellitus type II [1,2]. 
 
Ageing is characterized by a progressive decline in 
one's metabolic and physiological functions [3], the 
associated dysregulation of nutrient sensitivity, 
mitochondrial dysfunction and cellular apoptosis 




























in  basal  conditions  and  during  exercise,  with  plasma  S‐klotho  in  middle‐aged,  sedentary  adults.    BMR  was
measured  by  indirect  calorimetry  in  74  such  subjects  (53%  women;  age  53.7±5.1  years)  following  standard
procedures, and their fuel oxidation estimated via stoichiometric equations. The maximal fat oxidation during
exercise (MFO) and the intensity of exercise that elicits MFO (Fatmax) were determined using a walking graded
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eventually becoming harmful [4] Ageing is associated 
with a progressive decline in the basal metabolic rate 
(BMR), meal-induced thermogenesis and physical 
activity [5], resulting in a reduced total energy 
expenditure.  In part, this is responsible for the gradual 
weight increase and the deposition of visceral adipose 
tissue seen during ageing, which places people at 
greater risk of cardiometabolic disease and all-cause 
mortality [6].  
 
Over the last decade, numerous studies have examined 
the association between basal fuel oxidation and ageing-
related diseases, and a potential role for this oxidation 
has been proposed in the pathogenesis of subclinical 
atherosclerosis, hypertriglyceridaemia, liver steatosis 
and ventricular cardiac remodelling [7–9].  Ageing is 
positively associated with visceral adiposity, but in a 
study involving a large and heterogeneous adult 
population, no relationship was observed between basal 
substrate oxidation and chronological age [3]. Recent 
studies have suggested that chronological age is but a 
crude indicator of ageing.  Specific ageing biomarkers 
provide a more accurate picture; indeed, they provide a 
reliable tool for understanding and assessing ageing 
[10]. 
 
The α-klotho gene is thought to suppress ageing, 
extending life expectancy when it is overexpressed and 
inducing premature ageing when it is defective [11,12]. 
It is mainly expressed in the kidney, the parathyroid 
glands and the brain; its product is a type-1 single-pass 
transmembrane glycoprotein, the ectodomain of which 
is shed and released into the systemic circulation in 
soluble form (S-klotho) [13]. S-klotho has several 
functions related to the physiology of energy 
metabolism [14], including the regulation of glucose 
uptake, the enhancement of insulin sensitivity, the 
attenuation of cellular oxidative stress, and the 
suppression of chronic inflammation [15–17], which 
together are thought to invest it with anti-ageing 
properties. A recent study showed that plasma S-klotho 
is lower in individuals with diabetes mellitus type II,  
Table 1. Study participant characteristics. 
 N All N Men  N Women 
Age (years) 74 53.7 (5.1) 35 54.4 (5.3) 39 53.0 (5.0) 
S-Klotho plasma levels (pg/ml) 73 775.3 (363.7) 34 814.1 (452.2) 39 741.4 (265.6) 
Anthropometry and body composition 
Weight (kg) 74 75.7 (15.0) 35 87.4 (11.0) 39 65.3 (9.3)* 
Height (cm) 74 167.8 (9.8) 35 175.8 (6.5) 39 160.7 (6.1)* 
Body mass index (kg/m2) 74 26.7 (3.8) 35 28.3 (3.6) 39 25.3 (3.3)* 
Fat mass (kg) 74 30.0 (8.4) 35 30.9 (9.8) 39 29.2 (7.1) 
Fat mass (%) 74 39.9 (9.1) 35 34.7 (8.0) 39 44.5 (7.4)* 
Fat mass index (kg/m2) 74 10.7 (3.1) 35 10.0 (3.2) 39 11.4 (2.9) 
Visceral adipose tissue (g) 74 789.7 (387.1) 35 972.4 (392.0) 39 625.8 (303.4)* 
Lean mass (kg) 74 43.5 (11.7) 35 53.9 (6.5) 39 34.1 (5.8)* 
Lean mass index (kg/m2) 74 15.2 (2.9) 35 17.5 (20.0) 39 13.2 (1.8)* 
Basal metabolic rate and fuel oxidation under post-fast baseline conditions 
BMR (kcal/day)  71 1508.4 (364.5) 34 1805.5 (244.8) 37 1235.5 (208.4)* 
BMRLM (kcal/kgleanmass/day)  71 35.2 (7.2) 34 33.6 (5.3) 37 36.7 (8.4) 
BFox (g/min) 71 0.053 (0.040) 34 0.064 (0.050) 37 0.042 (0.025)* 
BFox (% BMR) 71 45.6 (30.0) 34 45.6 (32.7) 37 45.6 (27.7) 
BCHox (g/min) 71 0.112 (0.096) 34 0.138 (0.115) 37 0.089 (0.069)* 
BCHox (% BMR) 71 41.8 (32.0) 34 44.0 (34.7) 37 39.8 (29.0) 
Fuel oxidation during exercise 
MFO (g/min) 71 0.29 (0.09) 34 0.35 (0.09) 37 0.23 (0.04)* 
MFOLM (g/kgleanmass/min) 71 6.72 (1.61) 34 6.43 (1.49) 37 6.99 (1.70) 
Fatmax (%VO2max) 71 43.0 (10.4) 34 41.6 (10.3) 37 44.3 (10.6) 
Cardiorespiratory fitness 
VO2max (ml/min) 71 2339.2 (657.2) 34 2915.4 (373.2) 37 1809.7 (332.5)* 
VO2max (ml/kg/min) 71 30.5 (5.6) 34 33.3 (4.5) 37 27.9 (5.3)* 









(BCHox)  (E,  F)  with  plasma  S‐klotho  levels.  β  (unstandardized  regression  coefficient),  R2,  and  P  are  from  simple  linear  regression 
analysis. Abbreviations: BMRLM; Basal Metabolic Rate relative to lean mass. 
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and therefore a potential biomarker of this disease [18]. 
It thus seems plausible that individuals with a reduced 
BMR and an altered fuel oxidation in basal conditions 
and during exercise may have lower plasma S-klotho. 
The literature contains no studies on how BMR and fuel 
oxidation in basal conditions and during exercise may 
be related to chronological ageing, or whether they have 
any relationship with ageing biomarkers such as S-
klotho. The aim of the present work was to investigate 
the relationship of BMR and fuel oxidation in basal 




Table 1 summarises the descriptive characteristics of 
the study subjects. BMR and BMRLM showed no 
significant association with plasma S-klotho (Figure 1A 
and 1B; P>0.1), a result that persisted after controlling 
for age, sex and percentage fat mass (Table 2; P>0.05). 
A significant, negative association was detected 
between BCHox (expressed in g/min, and in % BMR) 
and plasma S-klotho (1E and 1F; all P≤0.001), while a 
significant positive association was seen between BFox 
(expressed in g/min, and in % BMR) and plasma S-
klotho (Figure 1C, and 1D; all P<0.001). These 
associations persisted after controlling for age, sex, and 
percentage fat mass (Table 2; P≤0.01). 
 
MFO was significantly associated with plasma S-klotho 
(Figure 2A; P=0.034, β=1104.7) even after controlling 
for age, sex, and percentage fat mass (Table 2; P≤0.04). 
Neither MFOLM nor Fatmax showed any relationship 
with plasma S-klotho (Figure 2B and 2C; all P>0.1), a 
finding that persisted after adjusting for age, sex, and 
percentage fat mass (Table 2; P>0.08). 
 
Neither BMR, BMRLM, BFox, BCHox, MFO, MFOLM 
nor Fatmax showed an association with chronological age 
(Figure 3 and Figure 4; all P>0.1); these findings 
persisted after adjusting for sex and percentage fat mass 
(Table 2). 
 
All of the above-mentioned analyses were also run 
adjusting for visceral adipose tissue, VO2max, 
objectively measured moderate-vigorous physical 
activity, and total energy intake, and all findings 




The main findings of the present study are that the 
capacity to oxidase fat in basal conditions and during 
exercise (i.e., MFO), are positively associated with 
plasma S-klotho, while BCHox is inversely associated 
with the latter, in middle-aged sedentary adults. Neither 




B),  and  the  intensity  of  exercise  that  elicits MFO  (Fatmax)  (C) 
with  plasma  S‐klotho.  β  (unstandardized  regression 
coefficient),  R2  and  P  are  from  simple  linear  regression 
analysis. Abbreviations: MFO; Maximal Fat Oxidation, MFOLM; 
Maximal Fat Oxidation  relative  to  lean mass, Fatmax;  Intensity 
of exercise that elicits MFO, VO2max; Maximal Oxygen Uptake. 
 





lean mass,  BFox;  Basal  Fat  Oxidation,  BCHox;  Basal  Carbohydrate  Oxidation, MFO; Maximal  Fat  Oxidation, MFOLM; Maximal  Fat  Oxidation  relative  to  lean mass, 
Fatmax; Intensity of exercise that elicits MFO, VO2max; Maximum Oxygen Uptake. 
  
 Plasma S-klotho concentration  
  Model 1 Model 2 Model 3 Model 4 
  P value β P value β P value β P value β 
BMR (kcal/day)  0.209 0.184 0.203 0.247 0.670 0.051 0.497 0.089 
BMRLM (kcal/ kgleanmass/day)  0.150 10.495 0.091 15.868 0.490 9.180 0.329 4.611 
BFox (g/min)  <0.001 3340.712 <0.001 5380.689 <0.001 4701.526 <0.001 2829.975 
BFox (% BMR)  0.001 3.536 <0.001 6.434 <0.001 5.895 0.002 3.211 
BCHox (g/min)  0.010 -887.501 <0.001 -2038.484 <0.001 -1723.932 <0.001 -1057.784 
BCHox (% BMR)  0.002 -3.204 <0.001 -6.145 <0.001 -5.580 0.002 -3.034 
MFO (g/min)  <0.001 1312.915 0.036 1429.228 0.009 715.126 0.003 1298.556 
MFOLM (g/kgleanmass/min)  0.956 1.120 0.294 -29.664 0.891 3.964 0.181 35.482 
Fatmax (% VO2max)  0.724 1.108 0.133 -6.349 0.078 -6.886 0.081 31.824 
                                          Chronological age   
   Model 2 Model 3 Model 4* 
    P value β P value β P value β 
BMR (kcal/day)    0.132 -0.004 0.627 0.001 0.075 -0.005 
BMRLM (kcal/ kgleanmass/day)    0.071 0.150 0.312 0.098 0.386 0.082 
BFox (g/min)    0.453 -55.185 0.370 -44.989 0.418 -50.895 
BFox (% BMR)    0.186 -1.426 0.505 0.042 0.106 0.118 
BCHox (g/min)    0.676 -0.471 0.301 0.065 0.114 0.128 
BCHox (% BMR)    0.279 -1.163 0.459 0.046 0.117 0.115 
MFO (g/min)    0.326 -8.231 0.678 2.874 0.315 -8.199 
MFOLM (g/kgleanmass/min)    0.089 0.627 0.282 0.426 0.298 0.401 
Fatmax (% VO2max)    0.106 -1.835 0.188 0.085 0.094 0.137 
 




Figure  3. Association  between  basal  metabolic  rate  (BMR)  (A,  B),  basal  fat  oxidation  (BFox)  (C,  D)  and  carbohydrate  oxidation 
(BCHox) (E, F) with age. β (unstandardized regression coefficient), R2 and P are from a simple linear regression analysis. Abbreviations: 
BMRLM; Basal Metabolic Rate relative to lean mass. 
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chronological age, either in basal conditions or during 
exercise.  
 
BMR accounts for ~70% of total energy expenditure, 
and is largely responsible for overall energy 
homeostasis [19]. BMR falls by 1-2% per decade after 
20 years of age, and is closely linked to the progressive 
reduction in lean mass seen with ageing [20]. Our group 
recently reported a strong association between lean 
mass and plasma S-klotho [21] but, paradoxically, no 
association was seen between BMR and plasma S-
klotho in the present work. This might be explained in 
that the age of the present subjects was quite 
homogeneous, and because factors (in addition to the 
lean mass) such us energy flux rates, mitochondrial 
proton leakage, protein turnover, and Na+–K+–ATPase 
activity can influence the BMR during ageing [22]. 
Future studies with larger sample sizes and with a wide 
range of subject ages are needed to confirm these 
findings, and to examine whether changes in BMR are 
associated with changes in plasma S-klotho.  
 
Metabolic flexibility, defined as the ability to increase 
fat oxidation upon increased fatty acid availability 
(decreasing carbohydrate oxidation), and/or to switch 
between fat and carbohydrate oxidation as the primary 
fuel source [19], undergoes important changes during 
the ageing process [20]. Ageing is characterized by a 
progressive qualitative and quantitative decline in lean 
mass, poor mitochondrial volume and efficiency, a 
reduction in type II muscle fibre size, lower capillary 
density, resistance to anabolic endocrine signals, and a 
more pro-inflammatory environment [4]. Together, 
these changes underlie the theoretical framework for the 
appearance of metabolic inflexibility with ageing, 
observed through an increased carbohydrate oxidation 
in different situations. Conflicting results have been 
reported over time regarding the relationship between 
basal fuel oxidation and ageing. Initially, some studies 
reported a reduced BFox in older individuals compared 
to their younger counterparts [21,22]. However, 
methodological issues may have influenced these 
findings (e.g., small sample sizes, narrow and limiting 
inclusion criteria, poorly defined age groups (young vs. 
old), different data collection methods, and the method 
of determining fuel oxidation, etc.).  In response, Siervo 
et al. [3], recently conducted an elegant study to 
examine the association between BFox and 
chronological age in a large cohort (3442 individuals 
(2465 women) aged 18-81 years), using a ventilated-
hood indirect calorimetry system to determine fuel 
oxidation. In agreement with the present findings, but 
contrary to their own hypothesis, these authors found no 
significant association between BFox and chronological 
ageing [3]. They suggested this lack of association 
might be explained by age-related changes in metabolic 
 
 
Figure  4. Association  between maximal  fat  oxidation  (MFO) 
(A, B), and the intensity of exercise that elicits MFO (Fatmax) (C) 
with  age.  β  (unstandardized  regression  coefficient),  R2  and  P 
are  from  a  simple  linear  regression  analysis.  Abbreviations: 
MFO; Maximal  Fat Oxidation, MFOLM; Maximal  Fat Oxidation 
relative  to  lean mass,  Fatmax;  Intensity  of  exercise  that  elicits 
MFO, VO2max; Maximal Oxygen Uptake. 
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flexibility becoming more evident when the fuel 
oxidation capacity becomes crucial in the regulation of 
metabolic homeostasis (i.e., in the post-prandial state) 
[3]. Although ageing has typically been understood in 
terms of chronological age, several studies have 
suggested that it is a crude yardstick given the 
heterogeneity in individuals' physiology and health-
related outcomes; further, the influence of ageing is 
different between individuals, and even at the 
organ/tissue level of the same individual [10]. 
Measuring biological ageing biomarkers might 
therefore provide a more valid and reliable tool for 
assessing and examining the ageing process [10]. 
 
S-klotho is understood to be a powerful anti-ageing 
biomarker. It functions as a human ageing-suppression 
molecule and has pleiotropic activities that result in the 
protection of tissues and organ [23,24] Indeed, previous 
studies have reported a positive relationship between 
plasma S-klotho and life span [25], and an inverse 
association with coronary artery disease [26], 
atherosclerosis [26], osteoporosis [27], calcinosis, 
stroke [28], acute and chronic kidney diseases [29], 
different cancers [30], salt-sensitive hypertension [31] 
and all-cause mortality [31]. The transmembrane klotho 
protein is an essential component of endocrine 
fibroblast growth factor (FGF) receptor complexes, 
which have a key role in the pathophysiology of 
ageing-related disorders via the mediation of phosphate 
and calcium homeostasis [24]. However, S-klotho 
cannot function as a soluble receptor of FGF, and a 
number of FGF-independent functions have been 
described for it in the homeostasis of energy 
metabolism [14,15,24]. The anti-ageing properties of S-
klotho have been thought partially owed to its specific 
metabolic function: 1) It inhibits insulin and insulin-
like growth factor I (IGF-1) receptors, preventing their 
phosphorylation by the modification of their glycans 
[12]. Insulin induces transmembrane klotho shedding, 
and the consequent increase in plasma S-klotho inhibits 
insulin signalling in peripheral tissues and impedes the 
prolonged action of insulin [15,24]. This partial 
inhibition of insulin and IGF-1 is an evolutionarily 
conserved mechanism for suppressing ageing via the 
enhancement of insulin sensitivity [15,24]. 2) After 
binding to different Wnt ligands, it inhibits Wnt 
signalling and promotes stem cell proliferation and 
survival [32]. 3) It increases resistance to oxidative 
stress by inhibiting FOXO phosphorylation and 
upregulating a number of antioxidant enzymes [33,34]. 
 
Recent studies have shown that S-klotho production is 
downregulated in persons with diabetes mellitus type 
II; such patients experience hyperglycaemia, insulin 
resistance and an attenuated resistance to oxidative 
stress [18]. The reduced presence of S-klotho in these 
individuals who are metabolically inflexible in 
response to different stressors [19] hints at metabolic 
flexibility and plasma S-klotho levels being closely 
associated - and the present work shows a strong 
association between metabolic flexibility (both under 
post-fast baseline conditions and during exercise) with 
plasma S-klotho.   
 
The present work suffers from a number of limitations. 
Given its cross-sectional design, no causal 
interpretation can be established; the sample size in 
relatively small; and only sedentary adults aged 40-65 
years were included. These findings may not be 
extrapolatable to older, younger, and/or trained 
individuals. 
 
In summary, the present results suggest that BFox and 
MFO are positively associated with the plasma S-
klotho concentration in middle-aged sedentary adults, 
whereas a negative association was observed between 
BCHox and plasma S-klotho concentration. However, 
no relationship was observed between BFox, BCHox 
and MFO with chronological age under either set of 
test conditions. These results have clinical 
implications, and support the idea that fat oxidation in 
basal conditions and during exercise are powerful 
predictors of biological ageing. Further studies are 
needed to examine whether metabolic flexibility in 
response to other stressors (e.g., the post-prandial 
state, or after cold exposure) are associated with 
plasma S-klotho. A longitudinal intervention aiming to 
improve fat oxidation should be performed to 
determine whether plasma S-klotho increases in 
parallel. 
 
MATERIALS AND METHODS 
 
Study design and participants 
 
This cross-sectional study was performed as part of the 
FIT-AGEING project clinicaltrial.gov: ID: 
NCT03334357) [35]. Eighty-nine middle-aged, 
sedentary adults were initially recruited, of whom 15 
were excluded from analysis due to problems in data 
collection or usage; the final number of study subjects 
was therefore 74 (~52% women) (Supplementary 
Figure S1). Subjects were recruited through 
advertisements distributed in the form of leaflets and 
via social networks and electronic media. The 
inclusion criteria were: (i) age 40-65 years old, (ii) 
practicing <20 min of physical activity on <3 days per 
week (self-reported), (iii) to be taking no drug or long-
term medication, (iv) to be a non-smoker, (v) to have 
no cardiometabolic illness, (vi) to not be pregnant, 
(vii) and to have experienced no significant weight 
change (<3 kg) in the past 12 weeks.  
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All subjects gave their written, informed consent to be 
included in accordance with the latest revision of the 
Declaration of Helsinki (2013). The study was 
approved by the Human Research Ethics Committee of 




All assessments were made at the Sport and Health 
University Research Institute (iMUDS, Granada, 
Spain) during September and October of 2016 and 
2017.  Subject weight and height were measured using 
a Seca model 799 scale and stadiometer (Seca, 
Hamburg, Germany), and the body mass index (BMI) 
calculated as (weight [kg]/ height2 [m]). Fat mass, 
visceral adipose tissue mass and lean mass were 
determined using a Discovery Wi dual-energy X-ray 
absorptiometer (Hologic, Inc., Bedford, MA, USA).  
The fat mass index and the lean mass index were 
calculated as (fat mass [kg]/ height2 [m]) and (lean 
mass [kg]/ height2 [m]) respectively. 
 
Subjects were told to arrive at the laboratory in a 
motor vehicle, and to avoid any moderate/vigorous 
physical activity in the previous 24 h/48 h 
respectively; all were required to confirm that they had 
met this condition.  BMR was determined by indirect 
calorimetry in a peaceful room at 22-24ºC and 35-45% 
humidity, at between 8 and 10 a.m. following a 12 h 
fast, using an Ultima CardiO2 metabolic cart 
(Medgraphics Corp, MN, USA) and employing a 
neoprene face-mask with no external ventilation [36]. 
The evening meal consumed by subjects prior to 
fasting was standardized: an egg omelette with fried 
tomato and boiled rice. The Ultima CardiO2 metabolic 
cart device assessed oxygen consumption (VO2) using 
a galvanic fuel cell, and carbon dioxide production 
(VCO2) via non-dispersive infrared analysis using a 
breath-by-breath system [37].  Prior to the start of 
BMR assessment, the subjects reclined on a bed for 
~30 min in a comfortable supine position, covered by a 
sheet [38,39]. Meanwhile, a gas calibration using two 
standard gas concentrations, and a flow calibration 
using a 3 L calibration syringe, were performed 
following the manufacturer's instructions. BMR and 
basal fuel oxidation were measured over a 30 min 
period in which the participants were instructed to 
breath normally, neither talking, fidgeting nor 
sleeping. The first 5 min of each dataset were 
discarded.  The coefficient of variance (CV) for VO2, 
VCO2, the respiratory exchange ratio (RER), and 
minute ventilation, were calculated for 5 min intervals 
(i.e., from the 1st to the 5th min, from 2nd to 6th, from 
3rd to 7th, etc). In accordance with previous studies 
[40,41], the 5 min periods that met steady-state gas 
exchange criteria (i.e., CV<10% in VO2, CO2, and 
minute ventilation, and CV<10% in RER) were then 
selected, and the 5 min period with the lowest CV for 
VO2, VCO2, RER, and minute ventilation chosen for 
further analysis (excluding those subjects with a RER 
of <0.7 or >1.0). Weir's abbreviated equation [42] was 
used to estimate the BMR, and Frayn equations [43] 
were used to estimate basal fat oxidation (BFox) and 
basal carbohydrate oxidation (BCHox) expressed in 
g/min. The BMR was also calculated with respect to 
the lean mass (BMRLM). The BFox and BCHox were 
also expressed as a percentage of the BMR.  
 
Maximal fat oxidation during exercise (MFO), and the 
intensity of exercise that elicits MFO (Fatmax), were 
determined via a walking graded exercise test on a 
H/P/Cosmos Pulsar treadmill (H/P/Cosmos Sports & 
Medical GmbH, Nussdorf-Traunstein, Germany). The 
maximum walking speed was assessed following the 
methodology used in previous studies [44–46].  The 
walking graded exercise test started with a warm-up at 
3.5 km/h and a 0% gradient, and the speed then 
increased by 1 km/h every 3 min until the maximum 
walking speed was reached. The gradient was then 
increased by 2% every 3 min until the RER was >1.0. 
The subjects wore a Model 7400 face mask (Hans 
Rudolph Inc, Kansas City, MO, USA) equipped with a 
prevent™ metabolic flow sensor (Medgraphics Corp, 
Minnesota, USA) connected to the Ultima CardiO2 
metabolic cart for measuring gas exchange. Gas and 
flow calibrations were performed following the 
manufacturer's instructions. VO2 and VCO2 data were 
averaged every 10 s using Breeze Suite software 
v.8.1.0.54. Fat oxidation was calculated from the 
respiratory quotients during the last 60 s of each stage 
in the graded exercise test, using standard indirect 
calorimetry equations [43]. As previously described, 
MFO and Fatmax were estimated via a 3rd polynomial 
curve with fat oxidation as a function of VO2max 
[3046]. The MFO was also determined with respect to 
lean mass (MFOLM). 
 
Following the modified Balke protocol [47], a 
maximal graded exercise test was used to determine 
VO2max on another day (interval 3-7 days).  Subjects 
were asked: (i) to fast for 3 to 5 h, but eating a 
complete meal just before, (ii) to avoid drugs and/or 
stimulants at least 24 h before the test, and (iii) to 
refrain from moderate and/or vigorous physical 
activity for 24 h/48 h before the test respectively. 
Briefly, the test began at a speed of 3.5 km/h (gradient 
0%), increasing until reaching 5.3 km/h.  The gradient 
was then increased by 1% every minute, keeping the 
treadmill speed constant until subject exhaustion. The 
heart rate was continuously monitored and recorded 
every 5 s using a Polar RS800 heart rate monitor 
(Polar Electro Oy, Kempele, Finland). 
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Blood samples were obtained from the antecubital vein 
in the morning just before BMR assessment.  Plasma S-
klotho was determined in ethylene diamine-acetic acid-
treated plasma using a solid-phase sandwich enzyme-
linked immunosorbent assay kit (Demeditec, Kiel, 
Germany).  Optical density was assessed at 450 nm ± 2 
nm. The intra- and inter-assay CV (3-10% each) was 





The normal distribution of all variables was confirmed 
using the Shapiro-Wilk test, visual histograms, Q-Q 
plots and box plots.  The Student t test for unpaired 
samples was used to examine differences in the results 
of male and female subjects.  Given the aim of the 
study, and the lack of any significant interaction 
between sex (all P>0.05), the appropriateness of fitting 
models for men and women were combined including 
sex as a covariable.  
 
Simple linear regression models were first used to 
examine the association of BMR, BMRLM, BFox, 
BCHox, MFO, MFOLM, and Fatmax with plasma S-
klotho. Multiple linear regression analyses were then 
conducted to study these associations while controlling 
for potential confounders: (i) Model 1 was adjusted for 
age; (ii) Model 2 for sex; and (iii) Model 3 for 
percentage fat mass. These potential confounders were 
selected on the basis of theoretical considerations and 
the results of stepwise regression.  Simple linear 
regression was also performed to examine the 
association of BMR, BMRLM, BFox, BCHox, MFO, 
MFOLM and Fatmax with chronological age. All 
calculations were made using the Statistical Package for 
the Social Sciences v.22.0 (IBM Corporation, Chicago, 
IL, USA). GraphPad Prism 5 software (GraphPad 
Software, San Diego, CA, USA) was used for graphical 
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Supplementary  Table  S1.  Association  between  energy  metabolism  outcomes  with  S‐Klotho  protein  and  age 
adjusted by visceral adipose tissue (Model 1), adjusted by VO2max (Model 2), adjusted by objectively measured 
moderate‐vigorous physical activity (Model 3), and by total energy intake (Model 4). 
 Plasma S-klotho concentration 
       Model 1      Model 2      Model 3      Model 4 
BMR (kcal/day)         0.126         0.142         0.226         0.140 
BMRLM (kcal/ kgleanmass/day)         0.634         0.146         0.500         0.836 
BFox (g/min)        <0.001        <0.001        <0.001        <0.001 
BFox (% BMR)        <0.001        <0.001        <0.001        <0.001 
BCHox (g/min)        <0.001        <0.001        <0.001        <0.001 
BCHox (% BMR)        <0.001        <0.001        <0.001        <0.001 
MFO (g/min)         0.024         0.014         0.032         0.023 
MFOLM (g/kgleanmass/min)         0.232         0.409         0.254         0.253 
Fatmax (% VO2max)         0.109         0.630         0.161         0.112 
                                          Chronological age 
       Model 1      Model 2      Model 3      Model 4 
BMR (kcal/day)         0.828         0.287         0.758         0.983 
BMRLM (kcal/ kgleanmass/day)         0.153         0.206         0.128         0.139 
BFox (g/min)         0.459         0.519         0.109         0.244 
BFox (% BMR)         0.834         0.806         0.116         0.374 
BCHox (g/min)         0.692         0.253         0.066         0.618 
BCHox (% BMR)         0.975         0.629         0.110         0.407 
MFO (g/min)         0.874         0.343         0.896         0.979 
MFOLM (g/kgleanmass/min)         0.155         0.168         0.147         0.132 
Fatmax (% VO2max)         0.275         0.918         0.051         0.655 
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Supplementary Figure S1. Flow‐chart showing recruitment of study subjects. BMI: body mass  index, CDV: cardiovascular, ECG: 
electrocardiogram. 
